<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Metab Brain Dis</journal-id><journal-id journal-id-type="iso-abbrev">Metab Brain Dis</journal-id><journal-title-group><journal-title>Metabolic Brain Disease</journal-title></journal-title-group><issn pub-type="ppub">0885-7490</issn><issn pub-type="epub">1573-7365</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39556255</article-id><article-id pub-id-type="pmc">PMC11573817</article-id>
<article-id pub-id-type="publisher-id">1457</article-id><article-id pub-id-type="doi">10.1007/s11011-024-01457-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Diacerein ameliorates thioacetamide-induced hepatic encephalopathy in rats via modulation of TLR4/AQP4/MMP-9 axis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Abd Elrazik</surname><given-names>Nesma A.</given-names></name><address><email>nesmahabalah@mans.edu.eg</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Abd El Salam</surname><given-names>Al Shaima G.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01k8vtd75</institution-id><institution-id institution-id-type="GRID">grid.10251.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 0342 6662</institution-id><institution>Department of Biochemistry, Faculty of Pharmacy, </institution><institution>Mansoura University, </institution></institution-wrap>Mansoura, 35516 Egypt </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>40</volume><issue>1</issue><elocation-id>10</elocation-id><history><date date-type="received"><day>7</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>27</day><month>9</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Astrocyte swelling, blood brain barrier (BBB) dissipation and the subsequent brain edema are serious consequences of persistent hyperammonemia in hepatic encephalopathy (HE) in which if inadequately controlled it will lead to brain death. The current study highlights the potential neuroprotective effect of diacerein against thioacetamide (TAA)-induced HE in acute liver failure rat model. HE was induced in male Sprague&#x02013;Dawley rats via I.P. injection of TAA (200&#x000a0;mg/kg) for three alternative times/week at 3<sup>rd</sup> week of the experiment. Diacerein (50&#x000a0;mg/kg) was gavaged for 14 days prior to induction of HE and for further 7 days together with TAA injection for an overall period of 21 days. Diacerein attenuated TAA-induced HE in acute liver failure rat model; as proofed by significant lowering of serum and brain ammonia concentrations, serum AST and ALT activities and significant attenuation of both brain and hepatic MDA contents and IL-1&#x003b2; with marked increases in GSH contents (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). The neuroprotective effect of diacerein was demonstrated by marked improvement of motor and cognitive deficits, brain histopathological changes; hallmarks of HE. As shown by immunohistochemical results, diacerein markedly downregulated brain TLR4 expression which in turn significantly increased the GFAP expression, and significantly decreased AQP4 expression; the astrocytes swelling biomarkers (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). Moreover, diacerein preserved BBB integrity via downregulation of MMP-9 mediated digestion of tight junction proteins such as occludin (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). Collectively, diacerein ameliorated cerebral edema and maintained BBB integrity via modulation of TLR4/AQP4/MMP-9 axis thus may decrease the progression of HE induced in acute liver failure.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Hepatic encephalopathy</kwd><kwd>Diacerein</kwd><kwd>TLR4</kwd><kwd>Aquaporin 4</kwd><kwd>GFAP </kwd><kwd>MMP-9</kwd></kwd-group><funding-group><award-group><funding-source><institution>Mansoura University</institution></funding-source></award-group><open-access><p>Open access funding provided by The Science, Technology &#x00026; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par14">Hepatic encephalopathy (HE) is a dysfunction in the brain due to liver insufficiency, which includes a broad spectrum of neuropsychiatric abnormalities like impaired memory, shortened attention, sleep disturbances, psychomotor dysfunction and cognitive abnormalities which may reach ultimately to coma (Hussien et al. <xref ref-type="bibr" rid="CR28">2022</xref>). HE leads to repeated hospitalizations, impairing life quality and increased rates of death (Agrawal et al. <xref ref-type="bibr" rid="CR4">2015</xref>).</p><p id="Par15">For induction of acute liver failure and HE in experimental animals, thioacetamide (TAA) is used owing to its good reproducibility and well-described liver and brain changes which similar to that occur in human (Lima et al. <xref ref-type="bibr" rid="CR39">2019</xref>). TAA is metabolized by cytochrome P450 to TAA-S-oxide which in turn stimulates generation of reactive oxygen species and hyperammonemia (Sepehrinezhad et al. <xref ref-type="bibr" rid="CR55">2021</xref>).</p><p id="Par16">During HE, deterioration in liver function leads to elevation in blood ammonia level that crosses the blood-brain barrier (BBB) (Suraweera et al. <xref ref-type="bibr" rid="CR60">2016</xref>). Hyperammonemia induces oxidative stress and releases the pro-inflammatory mediators <italic>via</italic> activation of toll-like receptor-4 (TLR4). The detoxification of ammonia in astrocytes and TLR4 stimulation result in excess water entry, astrocytes swelling and finally brain edema (El-Baz et al. <xref ref-type="bibr" rid="CR19">2021</xref>). Moreover, ammonia and oxidative stress can cause swelling of astrocytes through increasing in aquaporin 4 (AQP4) water channel expression accompanied with entrance of water into cells (Sepehrinezhad et al. <xref ref-type="bibr" rid="CR54">2020</xref>).</p><p id="Par17">Additionally, the neuro-inflammation leads to increase in brain matrix metalloproteinase 9 (MMP-9) level that digest tight junction proteins such as occludin causing apparent disruption in BBB integrity and hence cerebral edema (Dhanda and Sandhir <xref ref-type="bibr" rid="CR18">2018</xref>; Sepehrinezhad et al. <xref ref-type="bibr" rid="CR54">2020</xref>; Abo El gheit et al.&#x000a0;<xref ref-type="bibr" rid="CR25">2020</xref>).</p><p id="Par18">Decreasing inflammation has a beneficial therapeutic effect in curing cognitive dysfunction in HE (Lu et al. <xref ref-type="bibr" rid="CR43">2021</xref>). Diacerein, an anthraquinone derivative, is approved for osteoarthritis treatment. It possess a wide range of pharmacological activities involving anti-inflammatory and antioxidant effects (Abd-Ellatif et al.&#x000a0;<xref ref-type="bibr" rid="CR1">2019</xref>; Almezgagi et al. <xref ref-type="bibr" rid="CR7">2020</xref>). The anti-inflammatory activity of diacerein is attributed to its capability to inhibit the production of inflammatory cytokines such as interleukin-1 beta (IL-1&#x003b2;) and blocks its receptors, as well as the down-regulation of TLR4 signaling pathway activation (Ibrahim et al. <xref ref-type="bibr" rid="CR29">2021</xref>; Ali et al. <xref ref-type="bibr" rid="CR6">2023</xref>). Moreover, it has been reported that diacerein has a protective effect against acetaminophen hepatotoxicity and liver ischemia/reperfusion damage (Ibrahim et al. <xref ref-type="bibr" rid="CR29">2021</xref>; Ali et al. <xref ref-type="bibr" rid="CR6">2023</xref>; Mohamed Kamel et al. <xref ref-type="bibr" rid="CR45">2022</xref>). However, its effect on HE induced by TAA remains unclear.</p><p id="Par19">Thus, this study assessed the potential neuroprotective effect of diacerein on TAA-induced HE in rats and investigated its impact on brain edema and astrocyte swelling through TLR4 mediated inflammation, AQP4 channels and BBB integrity.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title> Chemicals</title><p id="Par20"><bold>TAA</bold> was purchased from Sigma&#x02013;Aldrich (St. Louis, MO, USA) and it was dissolved in 0.9% (w/v) NaCl for intraperitoneal (I.P.) administration.</p><p id="Par21"><bold>Diacerein</bold> was purchased from Eva Pharma Company (Cairo, Egypt) and it was suspended in 0.5% (w/v) carboxymethylcellulose (CMC) for oral administration.</p></sec><sec id="Sec4"><title>Animals and ethical statement</title><p id="Par22">Forty-eight male Sprague&#x02013;Dawley rats (7&#x02013;8 weeks age weighing 160&#x02013;200&#x000a0;g) were purchased from the Egyptian Organization for Biological Products and Vaccines (Giza, Egypt) and were kept under standard conditions (45&#x02013;55% humidity, temperature 25&#x02009;&#x000b1;&#x02009;2 <sup>&#x025e6;</sup>C, 12&#x000a0;h light/dark cycle, with free access to food and water). The experimental protocol was carried out in accordance with the Animal Care and Use Committee of Mansoura University (MU-ACUC), Egypt; MU-ACUC (PHARM.R.23.04.16), complied with &#x0201c;Guide for the Care and Use of Laboratory Animals&#x0201d; (National Research Council publication 8th ed, USA, 2011).</p></sec><sec id="Sec5"><title>Experimental design and sample collection</title><p id="Par23">Induction of HE has been done by I.P. injection of TAA (200&#x000a0;mg/kg) three times/week at three alternative days during the third week of the experiment. The duration of the experimental model was 21 days (Khodir and Said <xref ref-type="bibr" rid="CR37">2020</xref>).</p><p id="Par24">Rats were randomly divided into four groups (<italic>n</italic>&#x02009;=&#x02009;12/group) as follows: Normal; rats received CMC orally once daily for two weeks before first 0.9% NaCl injection and then 0.9% NaCl was injected 3 times in alternative days along with daily CMC administration on the third week of the experiment. Diacerein control; rats received diacerein (50&#x000a0;mg/kg/day, oral) (Ibrahim et al. <xref ref-type="bibr" rid="CR30">2022</xref>) once daily for two weeks before first 0.9% NaCl injection and then 0.9% NaCl was injected 3 times in alternative days along with daily diacerein administration on the third week of the experiment. HE; rats received the CMC orally/day for two weeks before first TAA injection and then TAA was injected 3 times in alternative days along with daily CMC administration on the third week of the experiment. HE&#x02009;+&#x02009;Diacerein; rats received diacerein (50&#x000a0;mg/kg/day, oral) (Ibrahim et al. <xref ref-type="bibr" rid="CR30">2022</xref>) for two weeks before first TAA injection and then TAA was injected 3 times in alternative days along with daily diacerein administration on the third week of the experiment (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic representation of the experimental design</p></caption><graphic xlink:href="11011_2024_1457_Fig1_HTML" id="d33e361"/></fig></p><p id="Par25">The started number of rats in HE group was 14 rats, and 2 rats died during the experiment.</p><p id="Par26">To prevent TAA-induced hypoglycemia and electrolyte imbalance, rats were injected subcutaneously with a solution containing 10% dextrose water mixed with a lactate ringer solution (25 mL/kg) every 12-hr. following the first injection of TAA (Baraka et al. <xref ref-type="bibr" rid="CR11">2020</xref>). Six rats from each group were used for measurement of brain water content and the other rats were used for biochemical parameters, immunohistochemical and histopathological analyses.</p><p id="Par27">At the end of the experimental period, behavioral analyses were assessed. Then, rats were weighed, anesthetized by sodium thiopental (nesdonal) (I.P., 40&#x000a0;mg kg<sup>&#x02212;1</sup>), and blood samples were collected by retro-orbital puncture and then centrifuged. The serum was obtained and frozen at &#x02212;&#x02009;80&#x000a0;&#x000b0;C for further biochemical analysis. Then rats were sacrificed via cervical dislocation. The liver was excised, rinsed in ice-cold phosphate-buffered saline (PBS) and weighed for calculation of liver/body weight index. The right lobe of the liver was fixed in a 10% phosphate buffered formalin solution for histopathological examination. The left lobe of the liver was homogenized in PBS for further biochemical assays. Then, the skull was cracked opened, the brain was extracted, rinsed in ice-cold saline, and weighed immediately for calculation of brain/body weight index. The right hemisphere was homogenized in ice-cold PBS for further biochemical assays and the left hemisphere was fixed in phosphate buffered formalin for histopathological and immunohistochemical examinations.</p></sec><sec id="Sec6"><title>Behavioral analysis</title><p id="Par28">The behavioral tests were implemented in the morning. The tests were manually tracked by a qualified observer (either live or via video recording) blinded to the experimental groups on day 23.</p><sec id="Sec7"><title>Rotarod test</title><p id="Par29">This test was conducted to evaluate the motor coordination of rodents. Accelerating rotarod apparatus (Model No. 7750; Ugo Basile) was used according to the method described in previous reports (Vijitruth et al. <xref ref-type="bibr" rid="CR62">2006</xref>; El-Marasy et al. <xref ref-type="bibr" rid="CR20">2019</xref>). Rats were trained (3 training sessions /day) for 3 successive days at fixed speed of 4 rotations/min (rpm) to achieve a stable performance. Afterward, on the 4th day, the rats were placed on the testing rod and the starting speed was 4&#x000a0;rpm which has been gradually increased to reach 40&#x000a0;rpm over 300&#x000a0;s. At the end of the experimental model, rats were replaced again for 300&#x000a0;s test session and the fall-off time was recorded.</p></sec><sec id="Sec8"><title>Morris water maze test</title><p id="Par30">The Morris water maze test was applied to examine place learning and memory. It employs equipment which composed of black rounded pool (45&#x000a0;cm depth and 150&#x000a0;cm diameter), filled with 30&#x000a0;cm water (temperature 24&#x02009;&#x000b1;&#x02009;2 &#x025e6;C). The pool was subdivided into four quarters (N, S, E, and W). A discreet circular platform (diameter of 10&#x000a0;cm) was placed in S quadrant 2&#x000a0;cm below the water surface and maintained in the same quadrant throughout the whole experiment. The rats were trained to leave swimming by jumping onto the platform (4 trials separated by a 5-min pause on day 22 of the experiment) to learn the place location of the platform. The four different quarters (N, S, E, and W) were used during the four trials as starting points. Each trial ended once the rat jumped onto the platform. If a rat cannot find the platform within a time limit of 120&#x000a0;s, it was guided to the platform and left on for 20&#x000a0;s. A testing trial was conducted 24&#x000a0;h after the last training trial. During the testing trial, latency to the 1st jump on the invisible platform (escape latency, sec) was reported by a qualified person (Khalaf et al. <xref ref-type="bibr" rid="CR36">2020</xref>).</p></sec><sec id="Sec9"><title>Open field test</title><p id="Par31">This test evaluates anxiety, locomotor activity levels, and exploratory behavior in rats. The open field test was done using an empty square arena (60&#x02009;&#x000d7;&#x02009;60&#x02009;&#x000d7;&#x02009;40&#x000a0;cm) with a central square area where the rat is placed in. Rat was allowed to freely explore the arena for a 5&#x000a0;min period and was videotaped. The resting time, line crossings, number of rearing and time spent in the central area were assessed as indicators of locomotor activity, exploratory behavior and anxiety (Fisher and Hughes <xref ref-type="bibr" rid="CR23">1996</xref>).</p></sec></sec><sec id="Sec10"><title>Assessment of liver and brain indices</title><p id="Par32">Liver and brain indices were assessed according to the following formulas:</p><p id="Par33"><inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Liver\:index\:=\:Liver\:weight\:/Total\:body\:weight\:\times\:100$$\end{document}</tex-math><inline-graphic xlink:href="11011_2024_1457_Article_IEq1.gif"/></alternatives></inline-formula> (Ali et al. <xref ref-type="bibr" rid="CR5">2016</xref>).</p><p id="Par34"><inline-formula id="IEq2"><alternatives><tex-math id="M2">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Brain\:index\:=\:Brain\:weight\:/Total\:body\:weight\:\times\:100$$\end{document}</tex-math><inline-graphic xlink:href="11011_2024_1457_Article_IEq2.gif"/></alternatives></inline-formula> (Liu et al. <xref ref-type="bibr" rid="CR40">2020</xref>).</p></sec><sec id="Sec11"><title>Measurement of brain water content</title><p id="Par35">Brain water content was determined by wet/dry weight technique (Shahrokhi et al.&#x000a0;<xref ref-type="bibr" rid="CR57">2010</xref>; Hajipour et al. <xref ref-type="bibr" rid="CR26">2021</xref>). The brain was removed from each rat and weighed before and after 48&#x000a0;h of incubation in a 100&#x000a0;&#x000b0;C oven. The brain water content of each rat was calculated using the following formula:</p><p id="Par36">
<disp-formula id="Equa"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{array}{l}\mathrm{Brain}\;\mathrm{water}\;\mathrm{content}\;\%\\=\lbrack\left(\mathrm{wet}\;\mathrm{tissue}\;\mathrm{weight}-\mathrm{dry}\;\mathrm{tissue}\;\mathrm{weight}\right)\\/\mathrm{wet}\;\mathrm{tissue}\;\mathrm{weight}\rbrack\times100\end{array}$$\end{document}</tex-math><graphic xlink:href="11011_2024_1457_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>
</p></sec><sec id="Sec12"><title>Assessed biochemical parameters</title><p id="Par37">Serum was used for the spectrophotometric measurement of liver function tests (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)) (Human, Wiesbaden, Germany). Serum and brain homogenates were used for measurement of ammonia concentrations (BioVision, USA). The liver and brain homogenates were used for spectrophotometric measurement of malondialdehyde (MDA) and reduced glutathione (GSH) contents (Bio-diagnostic Company, Giza, Egypt) and for ELISA measurement of IL-1&#x003b2; level (Cloud-Clone Corp, USA), according to the manufacturer instructions. Moreover, the levels of MMP-9 and occludin were measured in the brain tissue using commercially available ELISA kits (Cloud-Clone Corp, USA) and (elabscience, USA), respectively, according to the manufacturer instructions.</p></sec><sec id="Sec13"><title>Immunohistochemical and histopathological analyses</title><p id="Par38">Formalin fixed liver section and right frontal cortex section from left brain hemisphere were embedded in paraffin wax and sliced (4 to 5&#x000a0;&#x003bc;m) in thickness for staining with hematoxylin and eosin (H &#x00026; E) to assess structural changes. Three sections were used from each animal with 8&#x000a0;&#x003bc;m between each two sections. Five sampling windows were used in each section sized 100 &#x000b5;m<sup>2</sup>. The severity of histopathological changes in both liver and brain were quantified on a scale from 0 to 3. In liver sections, the scores were assessed according to the extent of degeneration, necrosis, and inflammation. In brain sections, the scores were determined according to the extent of apoptosis, astrocytes swelling, necrosis, and congestion of blood vessels.</p><p id="Par39">
<list list-type="bullet"><list-item><p id="Par40">Score 0: no changes,</p></list-item><list-item><p id="Par41">Score 1: mild changes; changes affecting &#x002c2;25% of the field,</p></list-item><list-item><p id="Par42">Score 2: moderate change; changes affecting 25&#x02013;75% of the field,</p></list-item><list-item><p id="Par43">Score 3: severe change; changes affecting &#x002c3;75% of the field.</p></list-item></list>
</p><p id="Par44">Brain occludin, glial fibrillary acidic protein (GFAP), AQP4 and TLR4 were assessed via immunohistochemistry technique. Briefly, formalin fixed brain slices from different groups were dewaxed and incubated at 4 &#x025e6;C overnight with primary antibodies against occludin (Biospes, Chongqing, China, Cat. No. YPA1281, dilution 1/100), GFAP (ServiceBio, Wuhan, China, Cat. No. GB11096, dilution 1/1000), AQP4 (ServiceBio, Wuhan, China, Cat. No. GB11529, dilution 1/600) and TLR4 (ServiceBio, Wuhan, China, Cat. No. GB12186, dilution 1/500). After washing, the samples were incubated with a species-matched secondary antibody for 60&#x000a0;min and visualized with diaminobenzidine. The percentage of stained area was determined using Image J software (NIH, USA) and will be further used for statistical analysis.</p></sec><sec id="Sec14"><title>Statistical analysis</title><p id="Par45">One-way analysis of variance (ANOVA) followed by Tukey&#x02019;s Post-hoc test was used for analysis of parametric data. Kruskal&#x02013;Wallis test followed by Dunn&#x02019;s post hoc test were used for analysis of non-parametric data. Statistical analyses and Graphs were carried out using GraphPad Prism version 8.0.0 (Graph Pad Software Inc., SanDiego, USA). Data were expressed as the mean&#x02009;&#x000b1;&#x02009;standard error of the mean (SEM). p values less than 0.05 were statistically significant.</p></sec></sec><sec id="Sec15"><title>Results</title><p id="Par46">The diacerein control group revealed non-significant differences in behavioral tests, brain water content, liver/body weight index, brain/body weight index, liver enzymes, serum and brain ammonia concentrations and both liver and brain histopathological lesions when compared with normal group.</p><sec id="Sec16"><title>Effect of diacerein on behavioral tests</title><p id="Par47">In rotarod test, HE group showed a marked decrease in fall-off time, compared with normal group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), indicating motor incoordination. While oral administration of 50&#x000a0;mg/kg diacerein ameliorate motor incoordination as it significantly increased fall-off time, compared with HE group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A), F (3, 20)&#x02009;=&#x02009;79.66, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.<fig id="Fig2"><label>Fig. 2</label><caption><p>Effect of diacerein on behavioral tests. <bold>(A)</bold> Rotarod test. <bold>(B)</bold> Morris water maze test. <bold>(C)</bold> Open field test. Open field test includes resting time, line crossings, rearing frequency and time spent in center. HE: Hepatic encephalopathy. Values are expressed as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using One-Way ANOVA followed by Tukey-Kramer&#x02019;s test (<italic>n</italic>&#x02009;=&#x02009;6). <sup>*</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05. <sup>**</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01. <sup>***</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001. <sup>****</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <sup>###</sup> Significantly different versus HE group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001. <sup>####</sup> Significantly different versus HE group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001</p></caption><graphic xlink:href="11011_2024_1457_Fig2_HTML" id="d33e546"/></fig></p><p id="Par48">Moreover, escape latency in Morris water maze test significantly increased in HE group, compared to normal rats (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). Treatment with diacerein was accompanied by improvement in learning and memory in HE-rats as noted by decrease in escape latency, compared with HE group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) <bold>(</bold>Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B), F (3, 20)&#x02009;=&#x02009;201.9, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.</p><p id="Par49">During open field test, HE group showed a significant elevation in resting time (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) and a substantial decrease in rearing frequency (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), line crossings (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) and time spent in center (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) as compared to normal group, indicating increased anxiety, impairment in exploratory behavior and locomotor activity. Diacerein treatment relieved anxiety and enhanced exploratory behavior as well as locomotor activity as implied by a significant diminution in resting time (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) and a marked increase in rearing frequency (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), line crossings (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) and time spent in center (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) as compared to HE rats (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C). Resting time (F (3, 20)&#x02009;=&#x02009;66.38, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), rearing frequency (F (3, 20)&#x02009;=&#x02009;47.76, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), line crossings (F (3, 20)&#x02009;=&#x02009;25.90, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) and time spent in center (F (3, 20)&#x02009;=&#x02009;29.73, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001).</p></sec><sec id="Sec17"><title>Effect of diacerein on brain water content</title><p id="Par50">A significant elevation in brain water content was observed in HE group in comparison with normal group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). However, diacerein treated group showed a significant reduction in brain water content as compared to HE group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A), F (3, 20)&#x02009;=&#x02009;106.1, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.<fig id="Fig3"><label>Fig. 3</label><caption><p>Effect of diacerein on brain water content, liver/body weight and brain/body weight indices. <bold>(A)</bold> Brain water content. <bold>(B)</bold> liver/body weight index. <bold>(C)</bold> Brain/body weight index. HE: Hepatic encephalopathy. Values are expressed as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using One-Way ANOVA followed by Tukey-Kramer&#x02019;s test (<italic>n</italic>&#x02009;=&#x02009;6). <sup>**</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01. <sup>****</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <sup>####</sup> Significantly different versus HE group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001</p></caption><graphic xlink:href="11011_2024_1457_Fig3_HTML" id="d33e658"/></fig></p></sec><sec id="Sec18"><title>Effect of diacerein on liver/body weight and brain/body weight indices</title><p id="Par51">As shown in (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B and C), HE group revealed a significant elevation in liver/body weight index, compared with normal group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). Moreover, brain/body weight index markedly increased in HE group compared with normal group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). However, treating rats with 50&#x000a0;mg/kg diacerein showed a significant decrease in both indices compared with HE group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). liver/body weight index (F (3, 20)&#x02009;=&#x02009;89, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) and brain/body weight index (F (4, 25)&#x02009;=&#x02009;295.7, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001).</p></sec><sec id="Sec19"><title>Effect of diacerein on liver enzymes, serum and brain ammonia concentrations</title><p id="Par52">HE group showed 5.2- and 4-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) significant elevation in serum ALT and AST activities, respectively as well as 6.9- and 4.1-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) marked increase in serum and brain ammonia concentrations in comparison with normal rats. However, treating rats with diacerein showed a marked reduction in serum ALT, AST activities, serum and brain ammonia concentrations by approximately 2.7-, 1.9-, 3.4- and 2.4-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) respectively compared with HE group (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). ALT (F (3, 20)&#x02009;=&#x02009;1092, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), AST (F (3, 20)&#x02009;=&#x02009;482.4, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), serum ammonia (F (3, 20)&#x02009;=&#x02009;1307, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), brain ammonia (F (3, 20)&#x02009;=&#x02009;3063, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Effect of diacerein on liver enzymes, serum and brain ammonia concentrations</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Groups</th><th align="left">Normal</th><th align="left">Diacerein control</th><th align="left">HE</th><th align="left">HE&#x02009;+&#x02009;Diacerein</th></tr></thead><tbody><tr><td align="left"><bold>ALT</bold> (IU/L)</td><td char="&#x000b1;" align="char">62.5&#x02009;&#x000b1;&#x02009;1.09</td><td char="&#x000b1;" align="char">47.5&#x02009;&#x000b1;&#x02009;1.77</td><td char="&#x000b1;" align="char">327&#x02009;&#x000b1;&#x02009;7.37<sup>****</sup></td><td char="&#x000b1;" align="char">122.16&#x02009;&#x000b1;&#x02009;1.49 <sup>*****, #####</sup></td></tr><tr><td align="left"><bold>AST</bold> (IU/L)</td><td char="&#x000b1;" align="char">152.83&#x02009;&#x000b1;&#x02009;2.49</td><td char="&#x000b1;" align="char">137.5&#x02009;&#x000b1;&#x02009;1.76</td><td char="&#x000b1;" align="char">617.67&#x02009;&#x000b1;&#x02009;19.74<sup>****</sup></td><td char="&#x000b1;" align="char">316.67&#x02009;&#x000b1;&#x02009;3.6 <sup>*****, #####</sup></td></tr><tr><td align="left"><bold>Serum ammonia</bold> (&#x000b5;g/dl)</td><td char="&#x000b1;" align="char">22.67&#x02009;&#x000b1;&#x02009;0.56</td><td char="&#x000b1;" align="char">21&#x02009;&#x000b1;&#x02009;1.00</td><td char="&#x000b1;" align="char">156.5&#x02009;&#x000b1;&#x02009;3.3<sup>****</sup></td><td char="&#x000b1;" align="char">45.5&#x02009;&#x000b1;&#x02009;0.67 <sup>*****, #####</sup></td></tr><tr><td align="left"><bold>Brain ammonia</bold> (nmol/g.tissue)</td><td char="&#x000b1;" align="char">441.2&#x02009;&#x000b1;&#x02009;14.05</td><td char="&#x000b1;" align="char">478.7&#x02009;&#x000b1;&#x02009;10.91</td><td char="&#x000b1;" align="char">1799&#x02009;&#x000b1;&#x02009;14.02<sup>****</sup></td><td char="&#x000b1;" align="char">756.2&#x02009;&#x000b1;&#x02009;3.91 <sup>*****, #####</sup></td></tr></tbody></table><table-wrap-foot><p>ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, HE: Hepatic encephalopathy</p><p>Values are expressed as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using One-Way ANOVA followed by Tukey-Kramer&#x02019;s test (<italic>n</italic>&#x02009;=&#x02009;6). <sup>****</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <sup>####</sup> Significantly different versus HE group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec20"><title> Effect of diacerein on histopathological alterations in liver</title><p id="Par53">Histopathological examination of H&#x00026;E-stained liver tissues revealed that intact liver arrangement of hepatic cords around central vein, normal portal areas and sinusoids with absence of any evidence of degeneration, necrosis, or inflammation in normal group. Rats treated with TAA in HE group showed a marked disrupted hepatic architecture, centrilobular pyknosis and apoptosis in hepatocytes (black arrow), significant congestion and hemorrhage (red arrow) accompanied with leukocytic cells infiltration lymphocytes, eosinophils and macrophages (yellow arrow). However, these findings were significantly ameliorated in the diacerein treated group, which showed improvement in histopathological picture of liver lobules and reduction in inflammation, apoptosis and congestion (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A and C).</p><p id="Par54">
<fig id="Fig4"><label>Fig. 4</label><caption><p>Effect of diacerein on histopathological alterations in liver and brain. <bold>(A)</bold> Histopathological changes of liver sections stained with H&#x00026;E. CV: Central vein. PT: portal areas. Black arrow indicates disrupted hepatic architecture, centrilobular pyknosis and apoptosis in hepatocytes. Red arrow indicates congestion and hemorrhage. The yellow arrow indicates leukocytic cells infiltration lymphocytes, eosinophils and macrophages. Upper panel (200X, bar 50&#x000a0;&#x003bc;m) and lower panel (400X, bar 20&#x000a0;&#x003bc;m). <bold>(B)</bold> Histopathological changes of brain sections stained with H&#x00026;E. Black arrow indicates pyramidal neurons. Yellow arrow indicates glial cells. Green arrow indicates shrinkage and apoptosis of pyramidal neurons. Red arrow indicates congestion and hemorrhage. Upper panel (200X, bar 50&#x000a0;&#x003bc;m) and lower panel (400X, bar 20&#x000a0;&#x003bc;m). <bold>(C)</bold> Liver histopathological lesion, scores are expressed as median and interquartile range. (<italic>n</italic>&#x02009;=&#x02009;6). <bold>(D)</bold> Brain histopathological lesion, scores are expressed as median and interquartile range. (<italic>n</italic>&#x02009;=&#x02009;6). HE: Hepatic encephalopathy. Statistical analysis was performed using Kruskal&#x02013;Wallis test followed by Dunn&#x02019;s post hoc test. <sup>*</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05. <sup>****</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <sup>####</sup> Significantly different versus HE group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001</p></caption><graphic xlink:href="11011_2024_1457_Fig4_HTML" id="d33e875"/></fig>
</p></sec><sec id="Sec21"><title> Effect of diacerein on histopathological alterations in brain</title><p id="Par55">In cross-sectional images of brain tissues stained with H&#x00026;E, Normal group showed normal structure of cerebral cortex, normal pyramidal neurons (black arrow), and glial cells (yellow arrow) with absence of any evidence of necrosis, astrocytes swelling, or inflammation. HE group revealed congestion and hemorrhage (red arrow), marked shrinkage and apoptosis (green arrow) of pyramidal neurons. Contrariwise, HE&#x02009;+&#x02009;Diacerein group showed significant amelioration in histological lesions of cerebral cortex and decreasing in inflammation, apoptosis, and congestion <bold>(</bold>Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B and D<bold>)</bold>.</p></sec><sec id="Sec22"><title> Effect of diacerein on TLR4 expression in brain</title><p id="Par56">As shown in (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>A and B), examination of immunostained brain sections from HE group showed a significant elevation in TLR4 expression by about 7.4-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), compared with normal group. Meanwhile, brain sections from HE&#x02009;+&#x02009;Diacerein group showed a notable decrease in the expression of TLR4 by 3.4-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) as compared to HE group, F (2, 15)&#x02009;=&#x02009;234.8, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.<fig id="Fig5"><label>Fig. 5</label><caption><p>Effect of diacerein on TLR4 and GFAP expressions in brain. <bold>A</bold>,<bold> B)</bold> The expression of TLR4 using immunohistochemistry, Bars represent the % area in brain sections stained with anti-TLR4 antibodies, Upper panel (200X, bar 50&#x000a0;&#x003bc;m) and lower panel (400X, bar 20&#x000a0;&#x003bc;m). <bold>C</bold>,<bold> D)</bold> The expression of GFAP using immunohistochemistry, Bars represent the % area in brain sections stained with anti-GFAP antibodies, Upper panel (200X, bar 50&#x000a0;&#x003bc;m) and lower panel (400X, bar 20&#x000a0;&#x003bc;m). HE: Hepatic encephalopathy. Values are expressed as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using One-Way ANOVA followed by Tukey-Kramer&#x02019;s test (<italic>n</italic>&#x02009;=&#x02009;6). <sup>**</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01. <sup>****</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <sup>####</sup> Significantly different versus HE group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001</p></caption><graphic xlink:href="11011_2024_1457_Fig5_HTML" id="d33e944"/></fig></p></sec><sec id="Sec23"><title> Effect of diacerein on GFAP expression in brain</title><p id="Par57">Immunostained sections from brain tissues revealed a significant reduction in GFAP expression by approximately 81% (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) in HE group as compared to normal group. However, brain specimens from diacerein treated group showed a marked surge in percentage area immunostained with GFAP by nearly 4-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), compared with HE group (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>C and D), F (2, 15)&#x02009;=&#x02009;108.4, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.</p></sec><sec id="Sec24"><title> Effect of diacerein on oxidative stress and inflammation in liver and brain</title><p id="Par58">HE group revealed 6- and 6.1-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) marked elevation in hepatic MDA and brain MDA contents, respectively and accompanied with 7.8- and 10.4-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) significant reduction in hepatic GSH and brain GSH contents, respectively, in comparison with normal group. Surprisingly, diacerein treatment exhibited a marked reduction in both hepatic and brain MDA contents as well as a significant increment in GSH contents in liver and brain, as compared to HE rats (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>A, B, C and D). Hepatic MDA (F (2, 15)&#x02009;=&#x02009;413.9, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), brain MDA (F (2, 15)&#x02009;=&#x02009;2148, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), hepatic GSH (F (2, 15)&#x02009;=&#x02009;773.4, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) and brain GSH (F (4, 25)&#x02009;=&#x02009;773.6, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001).<fig id="Fig6"><label>Fig. 6</label><caption><p>Effect of diacerein on oxidative stress and inflammation in liver and brain. <bold>(A)</bold> Hepatic MDA content. <bold>(B)</bold> Brain MDA content; <bold>(C)</bold> Hepatic GSH content. <bold>(D)</bold> Brain GSH content. <bold>(E)</bold> Hepatic IL-1&#x003b2; level. <bold>(F)</bold> Brain IL-1&#x003b2; level. HE: Hepatic encephalopathy</p></caption><graphic xlink:href="11011_2024_1457_Fig6_HTML" id="d33e1016"/></fig></p><p id="Par59">Values are expressed as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using One-Way ANOVA followed by Tukey-Kramer&#x02019;s test (<italic>n</italic>&#x02009;=&#x02009;6). <sup>**</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01. <sup>***</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001. <sup>****</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <sup>####</sup> Significantly different versus HE group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.</p><p id="Par60">As shown in (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>E and F), Hepatic and brain IL-1&#x003b2; level were significantly elevated in HE group by 4.6- and 6.3-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), respectively as compared to normal group. On the other hand, diacerein administration caused a significant diminution in IL-1&#x003b2; level in liver and brain by 3.4- and 3.9-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), respectively as compared to HE group. Hepatic IL-1&#x003b2; (F (2, 15)&#x02009;=&#x02009;698.1, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) and brain IL-1&#x003b2; (F (2, 15)&#x02009;=&#x02009;966.9, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001).</p></sec><sec id="Sec25"><title>Effect of diacerein on MMP-9 level in brain</title><p id="Par61">As shown in (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>A), remarkable increase in MMP-9 level in brain was detected in HE group as compared to normal group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). After 21 days of daily oral administration of diacerein, MMP-9 level in brain was decreased significantly by about 60.7% (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) in comparison with HE group, F (2, 15)&#x02009;=&#x02009;139.5, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.<fig id="Fig7"><label>Fig. 7</label><caption><p>Effect of diacerein on MMP-9 level, occludin level and expression in brain. <bold>(A)</bold> Brain MMP-9 level. <bold>(B)</bold> Brain occludin level using ELISA. <bold>C</bold>,<bold> D)</bold> The expression of occludin using immunohistochemistry, Bars represent the % area in brain sections stained with anti-occludin antibodies, Upper panel (200X, bar 50&#x000a0;&#x003bc;m) and lower panel (400X, bar 20&#x000a0;&#x003bc;m). HE: Hepatic encephalopathy. Values are expressed as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using One-Way ANOVA followed by Tukey-Kramer&#x02019;s test (<italic>n</italic>&#x02009;=&#x02009;6). <sup>*</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05. <sup>****</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <sup>####</sup> Significantly different versus HE group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001</p></caption><graphic xlink:href="11011_2024_1457_Fig7_HTML" id="d33e1115"/></fig></p></sec><sec id="Sec26"><title>Effect of diacerein on occludin level and expression in brain</title><p id="Par62">TAA administration in HE group caused a significant decrease in brain occludin level by 3-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), compared with normal group. Conversely, HE&#x02009;+&#x02009;Diacerein group showed a remarkable increase in occludin level in brain by 2.2-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001), compared with HE group (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>B), F (2, 15)&#x02009;=&#x02009;255, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.</p><p id="Par63">Immunohistochemical analysis of brain tissues exhibited a marked reduction of occludin positive staining in HE group by about 79.2% (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) as compared to normal group, while treatment with diacerein 50&#x000a0;mg/kg revealed a significant increase in occludin expression in brain in comparison with HE group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>C and D), F (2, 15)&#x02009;=&#x02009;39.1, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.</p></sec><sec id="Sec27"><title>Effect of diacerein on AQP4 expression in brain</title><p id="Par64">As shown in (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>A and B), TAA-induced HE in rats displayed significant elevation in % area immunostained with AQP4 in brain by nearly 21.7-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) as compared to normal group. Interestingly, administration of diacerein caused a remarkable decrease in brain AQP4 expression by approximately 5-folds (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) as compared to HE group, F (2, 15)&#x02009;=&#x02009;118.8, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001.<fig id="Fig8"><label>Fig. 8</label><caption><p>Effect of diacerein on AQP4 expression in brain. <bold>A</bold>,<bold> B)</bold> The expression of AQP4 using immunohistochemistry, Bars represent the % area in brain sections stained with anti-AQP4 antibodies, Upper panel (200X, bar 50&#x000a0;&#x003bc;m) and lower panel (400X, bar 20&#x000a0;&#x003bc;m). HE: Hepatic encephalopathy. Values are expressed as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using One-Way ANOVA followed by Tukey-Kramer&#x02019;s test (<italic>n</italic>&#x02009;=&#x02009;6). <sup>****</sup> Significantly different versus normal group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <sup>####</sup> Significantly different versus HE group at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001</p></caption><graphic xlink:href="11011_2024_1457_Fig8_HTML" id="d33e1189"/></fig></p></sec></sec><sec id="Sec28"><title>Discussion</title><p id="Par65">The current study provides new perspective on the neuroprotective effect of diacerein (50&#x000a0;mg/kg) through modulation of TLR4/AQP4/MMP-9 pathway in TAA-induced HE rat model. Diacerein significantly relieves motor and cognitive deficits, cerebral and hepatic histopathological changes, oxidative stress, hepatic function, hyperammonemia and cerebral edema in HE rats.</p><p id="Par66">Diacerein is a well-known anthraquinone derivative which is clinically used to treat osteoarthritis. Its therapeutic effect is related to its anti-inflammatory and antioxidant activities which recently has been shown to relieve testicular injury, nephrotoxicity, and hepatotoxicity (Almezgagi et al. <xref ref-type="bibr" rid="CR7">2020</xref>; Mohamed Kamel et al. <xref ref-type="bibr" rid="CR45">2022</xref>). The current study offers a new perspective neuroprotective effect of diacerein against TAA-induced HE in rats through investigating its protective impact on liver injury, hyperammonemia, cognitive and motor deficits, astrocyte swelling and BBB integrity.</p><p id="Par67">In the current study, I.P. injection of TAA at a dose of 200&#x000a0;mg/kg for three alternative days is a well standardized and validated method for the induction of acute liver failure and subsequent HE (Abdelaziz et al. <xref ref-type="bibr" rid="CR2">2015</xref>; Khodir and Said <xref ref-type="bibr" rid="CR37">2020</xref>). TAA induced liver damage was proofed by significant increased serum ALT and AST activities which indicates leakage and damage of hepatocyte&#x02019;s cell membrane integrity and function (Anbarasu et al. <xref ref-type="bibr" rid="CR8">2012</xref>; Farjam et al., <xref ref-type="bibr" rid="CR21">2012</xref>). Moreover, TAA induces hepatocyte&#x02019;s inflammation and oxidative stress as evidenced by significant increase in hepatic IL-1&#x003b2; level and hepatic MDA content along with significant decrease in hepatic GSH content, compared to normal group. Also, liver/body weight index was markedly increased in TAA treated rats when compared to normal rats, which indicates the incidence of acute liver failure, in parallel with former report (Khodir and Said <xref ref-type="bibr" rid="CR37">2020</xref>). Furthermore, histopathological examination of liver tissues revealed marked disrupted hepatic architecture, apoptosis, hemorrhage, and leukocytic cells infiltration, in agreement with previous studies (Khodir and Said <xref ref-type="bibr" rid="CR37">2020</xref>; de David et al. <xref ref-type="bibr" rid="CR17">2011</xref>).</p><p id="Par68">Taken together, damaged hepatocytes can&#x02019;t adequately eliminate gut-derived ammonia, as a result, ammonia enters the systemic circulation, and eventually the brain, where it exerts detrimental HE effects (Jayakumar and Norenberg <xref ref-type="bibr" rid="CR32">2018</xref>). In our study, TAA-induced HE rats showed significant elevation in serum and brain ammonia concentrations in comparison with normal rats, in consistent with the previous reports (Khodir and Said <xref ref-type="bibr" rid="CR37">2020</xref>; Saleh et al. <xref ref-type="bibr" rid="CR53">2021</xref>).</p><p id="Par69">Elevation of ammonia level was considered a key factor associated with HE- induced neurological disorders (El-Marasy et al. <xref ref-type="bibr" rid="CR20">2019</xref>; Heidari et al. <xref ref-type="bibr" rid="CR27">2016</xref>; Butterworth et al. <xref ref-type="bibr" rid="CR14">1987</xref>). In the present study, TAA-induced HE rats showed marked decline in the fall-off time in rotarod test and significant raise in the escape latency in Morris water maze test which reflects the impairment in motor coordination and memory, respectively, in agreement with the previous reports (El-Marasy et al. <xref ref-type="bibr" rid="CR20">2019</xref>; Jamshidzadeh et al. <xref ref-type="bibr" rid="CR31">2017</xref>). Besides, rats treated with TAA suffered from anxiety, impairment in exploratory behavior and locomotor activity as proved by significant decrease in the time spent in the central zone, line crossings and number of rearing along with significant increase in resting time in open field test as compared with the normal group, in agreement with the previous studies (Jamshidzadeh et al. <xref ref-type="bibr" rid="CR31">2017</xref>; Ferah Okkay et al. <xref ref-type="bibr" rid="CR22">2022</xref>).</p><p id="Par70">In fact, the state of hyperammonemia in TAA treated rats were also associated with marked neuronal histopathological changes. Brain tissues of TAA-treated rats revealed congestion, hemorrhage, apoptosis, and astrocytes swelling. Moreover, brain water content and brain/body weight index were markedly increased in TAA-induced HE rats as compared with normal rats. In agreement, HE-induced astrocyte swelling, and subsequent cerebral edema has been reported to be the initial step of brain injury. The progression of acute liver failure increased the risk of brain edema which may progress to brain herniation; a main cause of death (Perazzo et al. <xref ref-type="bibr" rid="CR50">2012</xref>).</p><p id="Par71">Oral administration of diacerein ameliorated TAA-induced liver injury and function as proofed by marked reduction in serum ALT and AST activities along with significant lowering of liver/body weight index and marked improvement in the histopathological features of liver lobules as reduction in inflammation and congestion, compared to HE group. Moreover, diacerein relieved hepatic inflammation and oxidative stress as evidenced by significant decrease in hepatic IL-1&#x003b2; level and hepatic MDA content along with significant increase in hepatic GSH content, compared to HE group. The hepatoprotective effect of diacerein was previously discussed in different animal models (Ibrahim et al. <xref ref-type="bibr" rid="CR29">2021</xref>; Bu et al. <xref ref-type="bibr" rid="CR13">2018</xref>; Wang et al. <xref ref-type="bibr" rid="CR63">2022</xref>; Abdelfattah et al.&#x000a0;<xref ref-type="bibr" rid="CR3">2023</xref>).</p><p id="Par72">Diacerein-treated rats showed improvement in motor coordination and memory in HE-rats as evidenced by significant increase in the fall-off time in rotarod test and significant decrease in the escape latency in Morris water maze test, respectively. Also, diacerein ameliorates anxiety, impairment in exploratory behavior and locomotor activity in HE rats as noted by significant elevation in the time spent in the center, line crossings and number of rearing along with significant lowering in resting time in open field test. This enhancement of motor and cognitive deficits may related to the effect of diacerein on lowering hyperammonemia, brain water content and brain/body weight index along with marked amelioration in brain histopathological changes. The neuroprotective effect of diacerein was reported in various animal models (Sharma and Mishra <xref ref-type="bibr" rid="CR58">2023</xref>; Karvat et al. <xref ref-type="bibr" rid="CR35">2023</xref>).</p><p id="Par73">As we have mentioned before, brain edema is a serious consequence of persistent hyperammonemia in which if inadequately controlled it will lead to brain death. One of the main causes of brain edema is astrocytes swelling. Astrocytes account for about one-third brain volume and play a crucial role in the homeostasis of the central nervous system. They contribute to formation and maintenance of the BBB, supplying energy for the neurons, neurotransmission, and regulation of metabolic and synaptic plasticity (Sepehrinezhad et al. <xref ref-type="bibr" rid="CR54">2020</xref>).</p><p id="Par74">One of the main constituents of astrocytes is GFAP; an astrocyte intermediate filament and contributes in the regulation of astrocyte&#x02019;s motility and morphology along with structural stability of astrocyte processes (Pekny and Wilhelmsson <xref ref-type="bibr" rid="CR49">2006</xref>). GFAP is considered as a marker of mature astrocytes (Li et al. <xref ref-type="bibr" rid="CR38">2020</xref>). A previous in vitro study revealed that exposure of cultured astrocytes to ammonia resulted in a significant decrease in GFAP gene expression along with cellular swelling, it suggested that loss of GFAP may alter the visco-elastic properties of the astrocyte&#x02019; membrane inducing cellular swelling and cerebral edema (Norenberg et al. <xref ref-type="bibr" rid="CR46">1990</xref>). Another study revealed loss of GFAP expression in postmortem cerebral tissues from HE patients who died as a result of brain herniation due to acute liver failure (Thumburu et al. <xref ref-type="bibr" rid="CR61">2014</xref>). In a harmony with the previous reports, our results showed a significant reduction in GFAP expression in immunostained brain sections of HE group as compared to normal group.</p><p id="Par75">The AQP4, is a water channel protein present in astrocytic foot processes that play a crucial role in cerebral water regulation (Badaut et al. <xref ref-type="bibr" rid="CR10">2011</xref>; Fukuda et al. <xref ref-type="bibr" rid="CR24">2012</xref>). In agreement with the previous reports, the current study showed a significant upregulation of AQP4 protein expression in brain tissues of HE group when compared to normal group, which correlates with HE astrocytes swelling and hence cerebral edema (Rama Rao et al. <xref ref-type="bibr" rid="CR52">2010</xref>; Margulies et al. <xref ref-type="bibr" rid="CR44">1999</xref>). It was reported that ammonia- treated cultured astrocytes revealed a significant increase in the AQP4 protein expression as well as astrocytes swelling, suggesting the role of AQP4 channels in astrocytic swelling in hyperammonemia (Rama Rao et al. <xref ref-type="bibr" rid="CR51">2003</xref>).</p><p id="Par76">Several mechanisms have been suggested to correlate the hyperammonemia and the increase in brain astrocytic AQP4 channels. Firstly, it is well known that oxidative stress represents a cornerstone in the pathogenesis of HE induced by hyperammonemia, as ammonia upregulates cellular free radicals and downregulates the endogenous antioxidants (Norenberg et al. <xref ref-type="bibr" rid="CR47">2004</xref>). It was reported that, oxidative stress upregulates AQP4 protein expression in cultured astrocyte (Arima et al.&#x000a0;<xref ref-type="bibr" rid="CR9">2003</xref>). On the other hand, antioxidant-treated astrocytic cultures revealed a significant downregulation of AQP4 and astrocyte swelling (Jayakumar et al. <xref ref-type="bibr" rid="CR33">2006</xref>). As showed in our study, HE group revealed significant elevation in brain MDA contents accompanied with significant lowering in brain GSH content. Secondly, hyperammonemia-induced neuro-inflammation/ microglia activation may also upregulate astrocytic AQP4 protein expression in the brain and subsequent cellular edema (Ohnishi et al. <xref ref-type="bibr" rid="CR48">2014</xref>). It was reported that, elevated microglia activation markers as IL-1&#x003b2;, accelerated the onset of encephalopathy while deletion of the IL-1&#x003b2; gene attenuated brain edema hence delayed encephalopathy (B&#x000e9;meur et al. <xref ref-type="bibr" rid="CR12">2010</xref>). In accordance, our results revealed a marked increase in brain IL-1&#x003b2; level in HE rats compared to normal rats. Together, oxidative stress and microglia activation induced by hyperammonemia promote upregulation of brain TLR4 and further astrocyte swelling, in a harmony with our results (Jayakumar et al.&#x000a0;<xref ref-type="bibr" rid="CR34">2014</xref>). In another study, acetaminophen does not produce brain edema in TLR-4 knock-out mice (Shah et al. <xref ref-type="bibr" rid="CR56">2013</xref>). Moreover, a recent study showed that attenuating TLR4 in TAA- induced HE model ameliorates neuro-inflammation, oxidative stress, astrocyte swelling and hence cerebral edema (Lu et al. <xref ref-type="bibr" rid="CR42">2020</xref>). In the present study, diacerein relieves astrocyte swelling and subsequent brain edema as proved by significant elevation in brain GFAP protein expression and brain GSH content along with downregulation of brain AQP4 and TLR4 proteins expression, brain IL-1&#x003b2; level and brain MDA content, when compared to HE group.</p><p id="Par77">Moreover, recent study revealed that the neuro-inflammation altered BBB permeability via upregulation of MMP-9 in acute hypobaric hypoxia related encephalopathy model (Liu et al. <xref ref-type="bibr" rid="CR41">2022</xref>). MMP-9 has been involved in BBB disruption via digestion of tight junction proteins such as occludin which can result in selective permeability to small molecules like water and ammonia (Chen et al. <xref ref-type="bibr" rid="CR15">2009</xref>, <xref ref-type="bibr" rid="CR16">2011</xref>). Several hepatic encephalopathy evidences revealed that MMP-9 activation and occludin suppression were contributed to the alterations in BBB permeability and hence brain edema (Skowro&#x00144;ska et al. <xref ref-type="bibr" rid="CR59">2012</xref>; Dhanda and Sandhir <xref ref-type="bibr" rid="CR18">2018</xref>). In agreement, our results showed a marked increase in brain MMP-9 level along with marked decrease in brain occludin protein level and tissue expression in HE group, compared to normal group. On the flip side, diacerein ameliorates alterations in BBB permeability as proved by significant decrease in brain MMP-9 level, and significant increase in brain occludin protein level and tissue expression, compared to HE rats.</p><p id="Par78">In conclusion, our findings revealed that diacerein has a promising neuroprotective effect and may decrease the progression of HE induced in acute liver failure. The neuroprotective effect of diacerein was proved by improvement of motor and cognitive deficits, brain histopathological changes and hepatic functions; hallmarks of HE. In addition, diacerein ameliorates hyperammonemia induced cerebral edema and maintains BBB integrity through modulation of TLR4/AQP4/MMP-9 axis. To the best of our knowledge, the present study is the first that might shed some light on the neuroprotective effect of diacerein in HE. So, more experimental studies are required to explore more molecular mechanisms that may support the neuroprotective effect of diacerein in HE models.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ALT</term><def><p id="Par2">Alanine aminotransferase</p></def></def-item><def-item><term>AST</term><def><p id="Par3">Aspartate aminotransferase</p></def></def-item><def-item><term>AQP4</term><def><p id="Par4">Aquaporin 4</p></def></def-item><def-item><term>GFAP</term><def><p id="Par5">Glial fibrillary acidic protein</p></def></def-item><def-item><term>BBB</term><def><p id="Par6">Blood brain barrier</p></def></def-item><def-item><term>GSH</term><def><p id="Par7">Glutathione</p></def></def-item><def-item><term>H&#x00026;E</term><def><p id="Par8">Hematoxylin and eosin</p></def></def-item><def-item><term>HE</term><def><p id="Par9">Hepatic encephalopathy</p></def></def-item><def-item><term>MMP-9</term><def><p id="Par10">matrix metalloproteinase 9</p></def></def-item><def-item><term>MDA</term><def><p id="Par11">Malondialdehyde</p></def></def-item><def-item><term>TAA</term><def><p id="Par12">Thioacetamide</p></def></def-item><def-item><term>TLR4</term><def><p id="Par13">Toll-like receptor-4</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Nesma A. Abd Elrazik: Conceptualization; performed the practical work, and Data acquisition; Formal analysis; Writing and revising the manuscript. Al Shaima G. Abd El Salam: Conceptualization; performed the practical work, and Data acquisition; Formal analysis; Writing and revising the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.</p><p>Open access funding provided by The Science, Technology &#x00026; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval</title><p id="Par79">Study protocols and animal care were approved by the Animal Care and Use Committee (MU-ACUC) (Approval Number: PHARM.R.23.04.16), Mansoura University, Egypt, in accordance with &#x0201c;Guide for the Care and Use of Laboratory Animals&#x0201d; (National Research Council publication 8th edition, USA, 2011).</p></notes><notes id="FPar2"><title>Consent to participate</title><p id="Par80">Not applicable.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par81">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par82">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Abd-ellatif</surname><given-names>RN</given-names></name><name><surname>Hegab</surname><given-names>II</given-names></name><name><surname>Atef</surname><given-names>MM</given-names></name><name><surname>Sadek</surname><given-names>MT</given-names></name><name><surname>Hafez</surname><given-names>YM</given-names></name></person-group><article-title>Diacerein protects against glycerol-induced acute kidney injury: modulating oxidative stress, inflammation, apoptosis and necroptosis</article-title><source>Chemico-Biol Interact</source><year>2019</year><volume>306</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2019.04.008</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Abd-ellatif RN, Hegab II, Atef MM, Sadek MT, Hafez YM (2019) Diacerein protects against glycerol-induced acute kidney injury: modulating oxidative stress, inflammation, apoptosis and necroptosis. Chemico-Biol Interact 306:47&#x02013;53</mixed-citation></citation-alternatives></ref><ref id="CR2"><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelaziz</surname><given-names>RR</given-names></name><name><surname>Elkashef</surname><given-names>WF</given-names></name><name><surname>Said</surname><given-names>E</given-names></name></person-group><article-title>Tranilast reduces serum IL-6 and IL-13 and protects against thioacetamide-induced acute liver injury and hepatic encephalopathy</article-title><source>Environ Toxicol Pharmacol</source><year>2015</year><volume>40</volume><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.etap.2015.06.019</pub-id><pub-id pub-id-type="pmid">26164743</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Abdelaziz RR, Elkashef WF, Said E (2015) Tranilast reduces serum IL-6 and IL-13 and protects against thioacetamide-induced acute liver injury and hepatic encephalopathy. Environ Toxicol Pharmacol 40:259&#x02013;267<pub-id pub-id-type="pmid">26164743</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelfattah</surname><given-names>AM</given-names></name><name><surname>Mahmoud</surname><given-names>SS</given-names></name><name><surname>EL-Wafaey</surname><given-names>DI</given-names></name><name><surname>Abdelgeleel</surname><given-names>HM</given-names></name><name><surname>ABDELHAMID</surname><given-names>AM</given-names></name></person-group><article-title>Diacerein ameliorates cholestasis-induced liver fibrosis in rat via modulating HMGB1/RAGE/NF-&#x003ba;B/JNK pathway and endoplasmic reticulum stress</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><fpage>11455</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-38375-4</pub-id><pub-id pub-id-type="pmid">37454204</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Abdelfattah AM, Mahmoud SS, EL-Wafaey DI, Abdelgeleel HM, ABDELHAMID AM (2023) Diacerein ameliorates cholestasis-induced liver fibrosis in rat via modulating HMGB1/RAGE/NF-&#x003ba;B/JNK pathway and endoplasmic reticulum stress. Sci Rep 13:11455<pub-id pub-id-type="pmid">37454204</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Umapathy</surname><given-names>S</given-names></name><name><surname>Dhiman</surname><given-names>RK</given-names></name></person-group><article-title>Minimal hepatic encephalopathy impairs quality of life</article-title><source>J Clin Experimental Hepatol</source><year>2015</year><volume>5</volume><fpage>S42</fpage><lpage>S48</lpage><pub-id pub-id-type="doi">10.1016/j.jceh.2014.11.006</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Agrawal S, Umapathy S, Dhiman RK (2015) Minimal hepatic encephalopathy impairs quality of life. J Clin Experimental Hepatol 5:S42&#x02013;S48</mixed-citation></citation-alternatives></ref><ref id="CR5"><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>MHH</given-names></name><name><surname>Messiha</surname><given-names>BAS</given-names></name><name><surname>Abdel-Latif</surname><given-names>HA-T</given-names></name></person-group><article-title>Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats</article-title><source>Pharm Biol</source><year>2016</year><volume>54</volume><fpage>1198</fpage><lpage>1208</lpage><pub-id pub-id-type="pmid">26134756</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Ali MHH, Messiha BAS, Abdel-Latif HA-T (2016) Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats. Pharm Biol 54:1198&#x02013;1208<pub-id pub-id-type="pmid">26134756</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><mixed-citation publication-type="other">Ali DM, Mahmoud MH, Rifaai RA, Fawzy MA, Atta M, Welson NN, Batiha GES, Alexiou A, Papadakis M, Abdelzaher WY (2023) Diacerein modulates TLR4/NF-&#x003ba;B/IL&#x02010;1&#x003b2; and TRPC1/CHOP signalling pathways in gentamicin&#x02010;induced parotid toxicity in rats. J Cell Mol Med 27:1735&#x02013;1744</mixed-citation></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Almezgagi</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Hezam</surname><given-names>K</given-names></name><name><surname>Shamsan</surname><given-names>E</given-names></name><name><surname>Gamah</surname><given-names>M</given-names></name><name><surname>Al-Shaebi</surname><given-names>F</given-names></name><name><surname>Abbas</surname><given-names>AB</given-names></name><name><surname>Shoaib</surname><given-names>M</given-names></name><name><surname>Saif</surname><given-names>B</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>Diacerein: recent insight into pharmacological activities and molecular pathways</article-title><source>Biomed Pharmacother</source><year>2020</year><volume>131</volume><fpage>110594</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110594</pub-id><pub-id pub-id-type="pmid">32858499</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Almezgagi M, Zhang Y, Hezam K, Shamsan E, Gamah M, Al-Shaebi F, Abbas AB, Shoaib M, Saif B, Han Y, Jia R, Zhang W (2020) Diacerein: recent insight into pharmacological activities and molecular pathways. Biomed Pharmacother 131:110594<pub-id pub-id-type="pmid">32858499</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Anbarasu</surname><given-names>C</given-names></name><name><surname>Rajkapoor</surname><given-names>B</given-names></name><name><surname>Bhat</surname><given-names>KS</given-names></name><name><surname>Giridharan</surname><given-names>J</given-names></name><name><surname>Amuthan</surname><given-names>AA</given-names></name><name><surname>Satish</surname><given-names>K</given-names></name></person-group><article-title>Protective effect of Pisonia aculeata on thioacetamide induced hepatotoxicity in rats</article-title><source>Asian Pac J Trop Biomed</source><year>2012</year><volume>2</volume><fpage>511</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(12)60087-2</pub-id><pub-id pub-id-type="pmid">23569961</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Anbarasu C, Rajkapoor B, Bhat KS, Giridharan J, Amuthan AA, Satish K (2012) Protective effect of Pisonia aculeata on thioacetamide induced hepatotoxicity in rats. Asian Pac J Trop Biomed 2:511&#x02013;515<pub-id pub-id-type="pmid">23569961</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><mixed-citation publication-type="other">Arima H, Yamamoto N, Sobue K, Umenishi F, Tada T, Katsuya H, Asai K (2003) Hyperosmolar mannitol stimulates expression of aquaporins 4 and 9 through a p38 mitogen-activated protein kinase-dependent pathway in rat astrocytes. J Biol Chem 278:44525&#x02013;44534</mixed-citation></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Badaut</surname><given-names>J</given-names></name><name><surname>Ashwal</surname><given-names>S</given-names></name><name><surname>Obenaus</surname><given-names>A</given-names></name></person-group><article-title>Aquaporins in Cerebrovascular Disease: a target for treatment of Brain Edema</article-title><source>Cerebrovasc Dis</source><year>2011</year><volume>31</volume><fpage>521</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1159/000324328</pub-id><pub-id pub-id-type="pmid">21487216</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Badaut J, Ashwal S, Obenaus A (2011) Aquaporins in Cerebrovascular Disease: a target for treatment of Brain Edema. Cerebrovasc Dis 31:521&#x02013;531<pub-id pub-id-type="pmid">21487216</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Baraka</surname><given-names>SM</given-names></name><name><surname>Saleh</surname><given-names>DO</given-names></name><name><surname>Ghaly</surname><given-names>NS</given-names></name><name><surname>Melek</surname><given-names>FR</given-names></name><name><surname>Din</surname><given-names>GE</given-names></name><name><surname>Khalil</surname><given-names>AA</given-names></name><name><surname>Said</surname><given-names>WKB</given-names></name><name><surname>Medhat</surname><given-names>AM</given-names></name></person-group><article-title>Flavonoids from Barnebydendron Riedelii leaf extract mitigate thioacetamide-induced hepatic encephalopathy in rats: the interplay of NF-&#x003ba;B/IL-6 and Nrf2/HO-1 signaling pathways</article-title><source>Bioorg Chem</source><year>2020</year><volume>105</volume><fpage>104444</fpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2020.104444</pub-id><pub-id pub-id-type="pmid">33197852</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Baraka SM, Saleh DO, Ghaly NS, Melek FR, Din GE, Khalil AA, Said WKB, M. M., Medhat AM (2020) Flavonoids from Barnebydendron Riedelii leaf extract mitigate thioacetamide-induced hepatic encephalopathy in rats: the interplay of NF-&#x003ba;B/IL-6 and Nrf2/HO-1 signaling pathways. Bioorg Chem 105:104444<pub-id pub-id-type="pmid">33197852</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><mixed-citation publication-type="other">B&#x000e9;meur C, Qu H, Desjardins P, Butterworth RF (2010) IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem Int 56:213&#x02013;215</mixed-citation></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Bu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Huo</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name></person-group><article-title>Hepatoprotective effect of rhein against methotrexate-induced liver toxicity</article-title><source>Eur J Pharmacol</source><year>2018</year><volume>834</volume><fpage>266</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2018.07.031</pub-id><pub-id pub-id-type="pmid">30031796</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Bu T, Wang C, Meng Q, Huo X, Sun H, Sun P, Zheng S, Ma X, Liu Z, Liu K (2018) Hepatoprotective effect of rhein against methotrexate-induced liver toxicity. Eur J Pharmacol 834:266&#x02013;273<pub-id pub-id-type="pmid">30031796</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Butterworth</surname><given-names>RF</given-names></name><name><surname>Gigu&#x000e8;re</surname><given-names>J-F</given-names></name><name><surname>Michaud</surname><given-names>J</given-names></name><name><surname>Lavoie</surname><given-names>J</given-names></name><name><surname>Layrargues</surname><given-names>GP</given-names></name></person-group><article-title>Ammonia: key factor in the pathogenesis of hepatic encephalopathy</article-title><source>Neurochemical Pathol</source><year>1987</year><volume>6</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/BF02833598</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Butterworth RF, Gigu&#x000e8;re J-F, Michaud J, Lavoie J, Layrargues GP (1987) Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochemical Pathol 6:1&#x02013;12</mixed-citation></citation-alternatives></ref><ref id="CR15"><mixed-citation publication-type="other">Chen F, Ohashi N, Li W, Eckman C, Nguyen JH (2009) Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology 50:1914&#x02013;1923</mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="other">Chen F, Hori T, Ohashi N, Baine A-M, Eckman CB, Nguyen JH (2011) Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure. Hepatology 53:1294&#x02013;1305</mixed-citation></ref><ref id="CR17"><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>De David</surname><given-names>C</given-names></name><name><surname>Rodrigues</surname><given-names>G</given-names></name><name><surname>Bona</surname><given-names>S</given-names></name><name><surname>Meurer</surname><given-names>L</given-names></name><name><surname>Gonz&#x000e1;lez-Gallego</surname><given-names>J</given-names></name><name><surname>Tu&#x000f1;&#x000f3;n</surname><given-names>MJ</given-names></name><name><surname>Marroni</surname><given-names>NP</given-names></name></person-group><article-title>Role of Quercetin in preventing Thioacetamide-Induced Liver Injury in rats</article-title><source>Toxicol Pathol</source><year>2011</year><volume>39</volume><fpage>949</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1177/0192623311418680</pub-id><pub-id pub-id-type="pmid">21885874</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">De David C, Rodrigues G, Bona S, Meurer L, Gonz&#x000e1;lez-Gallego J, Tu&#x000f1;&#x000f3;n MJ, Marroni NP (2011) Role of Quercetin in preventing Thioacetamide-Induced Liver Injury in rats. Toxicol Pathol 39:949&#x02013;957<pub-id pub-id-type="pmid">21885874</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanda</surname><given-names>S</given-names></name><name><surname>Sandhir</surname><given-names>R</given-names></name></person-group><article-title>Blood-brain barrier permeability is exacerbated in experimental model of hepatic Encephalopathy via MMP-9 activation and downregulation of tight Junction proteins</article-title><source>Mol Neurobiol</source><year>2018</year><volume>55</volume><fpage>3642</fpage><lpage>3659</lpage><pub-id pub-id-type="pmid">28523565</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Dhanda S, Sandhir R (2018) Blood-brain barrier permeability is exacerbated in experimental model of hepatic Encephalopathy via MMP-9 activation and downregulation of tight Junction proteins. Mol Neurobiol 55:3642&#x02013;3659<pub-id pub-id-type="pmid">28523565</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>El-Baz</surname><given-names>FK</given-names></name><name><surname>Elgohary</surname><given-names>R</given-names></name><name><surname>Salama</surname><given-names>A</given-names></name></person-group><article-title>Amelioration of hepatic encephalopathy using Dunaliella salina microalgae in rats: Modulation of hyperammonemia/TLR4</article-title><source>Biomed Res Int</source><year>2021</year><volume>2021</volume><fpage>8843218</fpage><pub-id pub-id-type="doi">10.1155/2021/8843218</pub-id><pub-id pub-id-type="pmid">33855084</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">El-Baz FK, Elgohary R, Salama A (2021) Amelioration of hepatic encephalopathy using Dunaliella salina microalgae in rats: Modulation of hyperammonemia/TLR4. Biomed Res Int 2021:8843218<pub-id pub-id-type="pmid">33855084</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>El-Marasy</surname><given-names>SA</given-names></name><name><surname>Awdan</surname><given-names>E</given-names></name><name><surname>Abd-Elsalam</surname><given-names>RM</given-names></name></person-group><article-title>Protective role of chrysin on thioacetamide-induced hepatic encephalopathy in rats</article-title><source>Chemico-Biol Interact</source><year>2019</year><volume>299</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2018.11.021</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">El-Marasy SA, Awdan E, S. A., Abd-Elsalam RM (2019) Protective role of chrysin on thioacetamide-induced hepatic encephalopathy in rats. Chemico-Biol Interact 299:111&#x02013;119</mixed-citation></citation-alternatives></ref><ref id="CR21"><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>FARJAM</surname><given-names>M</given-names></name><name><surname>DEHDAB</surname><given-names>P</given-names></name><name><surname>ABBASSNIA</surname><given-names>F</given-names></name><name><surname>MEHRABANI</surname><given-names>D</given-names></name><name><surname>IMANIEH</surname><given-names>MH</given-names></name></person-group><article-title>Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes</article-title><source>Iran Red Crescent Med J</source><year>2012</year><volume>14</volume><fpage>164</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">22737573</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">FARJAM M, DEHDAB P, ABBASSNIA F, MEHRABANI D, TANIDEH, N., PAKBAZ, S., IMANIEH MH (2012) Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes. Iran Red Crescent Med J 14:164&#x02013;170<pub-id pub-id-type="pmid">22737573</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferah Okkay</surname><given-names>I</given-names></name><name><surname>Okkay</surname><given-names>U</given-names></name><name><surname>Gundogdu</surname><given-names>OL</given-names></name><name><surname>Bayram</surname><given-names>C</given-names></name><name><surname>Mendil</surname><given-names>AS</given-names></name><name><surname>Ertugrul</surname><given-names>MS</given-names></name><name><surname>Hacimuftuoglu</surname><given-names>A</given-names></name></person-group><article-title>Syringic acid protects against thioacetamide-induced hepatic encephalopathy: behavioral, biochemical, and molecular evidence</article-title><source>Neurosci Lett</source><year>2022</year><volume>769</volume><fpage>136385</fpage><pub-id pub-id-type="doi">10.1016/j.neulet.2021.136385</pub-id><pub-id pub-id-type="pmid">34871743</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Ferah Okkay I, Okkay U, Gundogdu OL, Bayram C, Mendil AS, Ertugrul MS, Hacimuftuoglu A (2022) Syringic acid protects against thioacetamide-induced hepatic encephalopathy: behavioral, biochemical, and molecular evidence. Neurosci Lett 769:136385<pub-id pub-id-type="pmid">34871743</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>CE</given-names></name><name><surname>Hughes</surname><given-names>RN</given-names></name></person-group><article-title>Effects of diazepam and cyclohexyladenosine on open-field behavior in rats perinatally exposed to caffeine</article-title><source>Life Sci</source><year>1996</year><volume>58</volume><fpage>701</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1016/S0024-3205(96)80009-9</pub-id><pub-id pub-id-type="pmid">8594320</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Fisher CE, Hughes RN (1996) Effects of diazepam and cyclohexyladenosine on open-field behavior in rats perinatally exposed to caffeine. Life Sci 58:701&#x02013;709<pub-id pub-id-type="pmid">8594320</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>AM</given-names></name><name><surname>Pop</surname><given-names>V</given-names></name><name><surname>Spagnoli</surname><given-names>D</given-names></name><name><surname>Ashwal</surname><given-names>S</given-names></name><name><surname>Obenaus</surname><given-names>A</given-names></name><name><surname>Badaut</surname><given-names>J</given-names></name></person-group><article-title>Delayed increase of astrocytic aquaporin 4 after juvenile traumatic brain injury: possible role in edema resolution?</article-title><source>Neuroscience</source><year>2012</year><volume>222</volume><fpage>366</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.06.033</pub-id><pub-id pub-id-type="pmid">22728101</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Fukuda AM, Pop V, Spagnoli D, Ashwal S, Obenaus A, Badaut J (2012) Delayed increase of astrocytic aquaporin 4 after juvenile traumatic brain injury: possible role in edema resolution? Neuroscience 222:366&#x02013;378<pub-id pub-id-type="pmid">22728101</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Gheit</surname><given-names>AE</given-names></name><name><surname>Atef</surname><given-names>RE</given-names></name><name><surname>Badawi</surname><given-names>MM</given-names></name><name><surname>Elwan</surname><given-names>GA</given-names></name><name><surname>Alshenawy</surname><given-names>WM</given-names></name><name><surname>Emam</surname><given-names>MN</given-names></name></person-group><article-title>Role of serine protease inhibitor, ulinastatin, in rat model of hepatic encephalopathy: aquaporin 4 molecular targeting and therapeutic implication</article-title><source>J Physiol Biochem</source><year>2020</year><volume>76</volume><fpage>573</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1007/s13105-020-00762-0</pub-id><pub-id pub-id-type="pmid">32794154</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Gheit AE, Atef RE, Badawi MM, Elwan GA, Alshenawy WM, H. A., Emam MN (2020) Role of serine protease inhibitor, ulinastatin, in rat model of hepatic encephalopathy: aquaporin 4 molecular targeting and therapeutic implication. J Physiol Biochem 76:573&#x02013;586<pub-id pub-id-type="pmid">32794154</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Hajipour</surname><given-names>S</given-names></name><name><surname>Sarkaki</surname><given-names>A</given-names></name><name><surname>Dianat</surname><given-names>M</given-names></name><name><surname>Rashno</surname><given-names>M</given-names></name><name><surname>Khorsandi</surname><given-names>LS</given-names></name><name><surname>Farbood</surname><given-names>Y</given-names></name></person-group><article-title>The effects of thymoquinone on memory impairment and inflammation in rats with hepatic encephalopathy induced by thioacetamide</article-title><source>Metab Brain Dis</source><year>2021</year><volume>36</volume><fpage>991</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1007/s11011-021-00688-6</pub-id><pub-id pub-id-type="pmid">33620578</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Hajipour S, Sarkaki A, Dianat M, Rashno M, Khorsandi LS, Farbood Y (2021) The effects of thymoquinone on memory impairment and inflammation in rats with hepatic encephalopathy induced by thioacetamide. Metab Brain Dis 36:991&#x02013;1002<pub-id pub-id-type="pmid">33620578</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Heidari</surname><given-names>R</given-names></name><name><surname>jamshidzadeh</surname><given-names>A</given-names></name><name><surname>niknahad</surname><given-names>H</given-names></name><name><surname>Mardani</surname><given-names>E</given-names></name><name><surname>Ommati</surname><given-names>MM</given-names></name><name><surname>Azarpira</surname><given-names>N</given-names></name><name><surname>Khodaei</surname><given-names>F</given-names></name><name><surname>Zarei</surname><given-names>A</given-names></name><name><surname>ayarZadeh</surname><given-names>M</given-names></name><name><surname>Mousavi</surname><given-names>S</given-names></name><name><surname>Abdoli</surname><given-names>N</given-names></name><name><surname>Yeganeh</surname><given-names>BS</given-names></name><name><surname>Saeedi</surname><given-names>A</given-names></name><name><surname>Najibi</surname><given-names>A</given-names></name></person-group><article-title>Effect of taurine on chronic and acute liver injury: focus on blood and brain ammonia</article-title><source>Toxicol Rep</source><year>2016</year><volume>3</volume><fpage>870</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1016/j.toxrep.2016.04.002</pub-id><pub-id pub-id-type="pmid">28959615</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Heidari R, jamshidzadeh A, niknahad H, Mardani E, Ommati MM, Azarpira N, Khodaei F, Zarei A, ayarZadeh M, Mousavi S, Abdoli N, Yeganeh BS, Saeedi A, Najibi A (2016) Effect of taurine on chronic and acute liver injury: focus on blood and brain ammonia. Toxicol Rep 3:870&#x02013;879<pub-id pub-id-type="pmid">28959615</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Hussien</surname><given-names>YA</given-names></name><name><surname>Mansour</surname><given-names>DF</given-names></name><name><surname>Nada</surname><given-names>SA</given-names></name><name><surname>Abd El-Rahman</surname><given-names>SS</given-names></name><name><surname>Abdelsalam</surname><given-names>RM</given-names></name><name><surname>Attia</surname><given-names>AS</given-names></name><name><surname>El-Tanbouly</surname><given-names>DM</given-names></name></person-group><article-title>Linagliptin attenuates thioacetamide-induced hepatic encephalopathy in rats: modulation of C/EBP-&#x003b2; and CX3CL1/Fractalkine, neuro-inflammation, oxidative stress and behavioral defects</article-title><source>Life Sci</source><year>2022</year><volume>295</volume><fpage>120378</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2022.120378</pub-id><pub-id pub-id-type="pmid">35134437</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Hussien YA, Mansour DF, Nada SA, Abd El-Rahman SS, Abdelsalam RM, Attia AS, El-Tanbouly DM (2022) Linagliptin attenuates thioacetamide-induced hepatic encephalopathy in rats: modulation of C/EBP-&#x003b2; and CX3CL1/Fractalkine, neuro-inflammation, oxidative stress and behavioral defects. Life Sci 295:120378<pub-id pub-id-type="pmid">35134437</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>MA</given-names></name><name><surname>Abdelzaher</surname><given-names>WY</given-names></name><name><surname>Ibrahim</surname><given-names>YF</given-names></name><name><surname>Ahmed</surname><given-names>AF</given-names></name><name><surname>Welson</surname><given-names>NN</given-names></name><name><surname>AL-Rashed</surname><given-names>S</given-names></name><name><surname>Batiha</surname><given-names>GE-S</given-names></name><name><surname>Abdel-Aziz</surname><given-names>AM</given-names></name></person-group><article-title>Diacerein protects rats with liver ischemia/reperfusion damage: down-regulation of TLR4/ NF&#x003ba;-B signaling pathway</article-title><source>Biomed Pharmacother</source><year>2021</year><volume>134</volume><fpage>111063</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2020.111063</pub-id><pub-id pub-id-type="pmid">33348310</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Ibrahim MA, Abdelzaher WY, Ibrahim YF, Ahmed AF, Welson NN, AL-Rashed S, Batiha GE-S, Abdel-Aziz AM (2021) Diacerein protects rats with liver ischemia/reperfusion damage: down-regulation of TLR4/ NF&#x003ba;-B signaling pathway. Biomed Pharmacother 134:111063<pub-id pub-id-type="pmid">33348310</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>YF</given-names></name><name><surname>Alorabi</surname><given-names>M</given-names></name><name><surname>Abdelzaher</surname><given-names>WY</given-names></name><name><surname>Toni</surname><given-names>NDM</given-names></name><name><surname>Thabet</surname><given-names>K</given-names></name><name><surname>Hegazy</surname><given-names>A</given-names></name><name><surname>Bahaa</surname><given-names>HA</given-names></name><name><surname>Batiha</surname><given-names>GE-S</given-names></name><name><surname>Welson</surname><given-names>NN</given-names></name><name><surname>Morsy</surname><given-names>MA</given-names></name><name><surname>Venugopala</surname><given-names>KN</given-names></name><name><surname>Abdel-Aziz</surname><given-names>AM</given-names></name></person-group><article-title>Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats</article-title><source>Biomed Pharmacother</source><year>2022</year><volume>149</volume><fpage>112870</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2022.112870</pub-id><pub-id pub-id-type="pmid">35367769</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Ibrahim YF, Alorabi M, Abdelzaher WY, Toni NDM, Thabet K, Hegazy A, Bahaa HA, Batiha GE-S, Welson NN, Morsy MA, Venugopala KN, Abdel-Aziz AM (2022) Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats. Biomed Pharmacother 149:112870<pub-id pub-id-type="pmid">35367769</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Jamshidzadeh</surname><given-names>A</given-names></name><name><surname>Heidari</surname><given-names>R</given-names></name><name><surname>Abasvali</surname><given-names>M</given-names></name><name><surname>Zarei</surname><given-names>M</given-names></name><name><surname>Ommati</surname><given-names>MM</given-names></name><name><surname>Abdoli</surname><given-names>N</given-names></name><name><surname>Khodaei</surname><given-names>F</given-names></name><name><surname>Yeganeh</surname><given-names>Y</given-names></name><name><surname>Jafari</surname><given-names>F</given-names></name><name><surname>Zarei</surname><given-names>A</given-names></name><name><surname>Latifpour</surname><given-names>Z</given-names></name><name><surname>Mardani</surname><given-names>E</given-names></name><name><surname>Azarpira</surname><given-names>N</given-names></name><name><surname>Asadi</surname><given-names>B</given-names></name><name><surname>Najibi</surname><given-names>A</given-names></name></person-group><article-title>Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia</article-title><source>Biomed Pharmacother</source><year>2017</year><volume>86</volume><fpage>514</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.11.095</pub-id><pub-id pub-id-type="pmid">28024286</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Jamshidzadeh A, Heidari R, Abasvali M, Zarei M, Ommati MM, Abdoli N, Khodaei F, Yeganeh Y, Jafari F, Zarei A, Latifpour Z, Mardani E, Azarpira N, Asadi B, Najibi A (2017) Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia. Biomed Pharmacother 86:514&#x02013;520<pub-id pub-id-type="pmid">28024286</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Jayakumar</surname><given-names>AR</given-names></name><name><surname>Norenberg</surname><given-names>MD</given-names></name></person-group><article-title>Hyperammonemia in hepatic Encephalopathy</article-title><source>J Clin Experimental Hepatol</source><year>2018</year><volume>8</volume><fpage>272</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.jceh.2018.06.007</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Jayakumar AR, Norenberg MD (2018) Hyperammonemia in hepatic Encephalopathy. J Clin Experimental Hepatol 8:272&#x02013;280</mixed-citation></citation-alternatives></ref><ref id="CR33"><mixed-citation publication-type="other">Jayakumar A, Panickar K, Murthy CR, Norenberg M (2006) Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J Neurosci 26:4774&#x02013;4784</mixed-citation></ref><ref id="CR34"><mixed-citation publication-type="other">Jayakumar AR, Tong XY, Curtis KM, Ruiz-Cordero R, Abreu MT, Norenberg MD (2014) Increased toll&#x02010;like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy. J Neurochem 128:890&#x02013;903</mixed-citation></ref><ref id="CR35"><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Karvat</surname><given-names>J</given-names></name><name><surname>Andrade</surname><given-names>TES</given-names></name><name><surname>Kraus</surname><given-names>SI</given-names></name><name><surname>Beppler</surname><given-names>LM</given-names></name><name><surname>De Jesus</surname><given-names>G</given-names></name><name><surname>Ferreira</surname><given-names>DSC</given-names></name><name><surname>Da Silva</surname><given-names>MD</given-names></name></person-group><article-title>Drug repositioning: diacerein as a new therapeutic approach in a mice model of sciatic nerve injury</article-title><source>Pharmacol Rep</source><year>2023</year><volume>75</volume><fpage>358</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1007/s43440-023-00461-9</pub-id><pub-id pub-id-type="pmid">36809646</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Karvat J, Andrade TES, Kraus SI, Beppler LM, De Jesus G, Ferreira DSC, J. B., Da Silva MD (2023) Drug repositioning: diacerein as a new therapeutic approach in a mice model of sciatic nerve injury. Pharmacol Rep 75:358&#x02013;375<pub-id pub-id-type="pmid">36809646</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Khalaf</surname><given-names>NEA</given-names></name><name><surname>Banna</surname><given-names>E</given-names></name><name><surname>Youssef</surname><given-names>FM</given-names></name><name><surname>Mosaad</surname><given-names>MY</given-names></name><name><surname>Daba</surname><given-names>YM</given-names></name><name><surname>Ashour</surname><given-names>RH</given-names></name></person-group><article-title>Clopidogrel combats neuroinflammation and enhances learning behavior and memory in a rat model of Alzheimer&#x02019;s disease</article-title><source>Pharmacol Biochem Behav</source><year>2020</year><volume>195</volume><fpage>172956</fpage><pub-id pub-id-type="doi">10.1016/j.pbb.2020.172956</pub-id><pub-id pub-id-type="pmid">32474163</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Khalaf NEA, Banna E, Youssef FM, Mosaad MY, Daba YM, M.-H. Y., Ashour RH (2020) Clopidogrel combats neuroinflammation and enhances learning behavior and memory in a rat model of Alzheimer&#x02019;s disease. Pharmacol Biochem Behav 195:172956<pub-id pub-id-type="pmid">32474163</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Khodir</surname><given-names>AE</given-names></name><name><surname>Said</surname><given-names>E</given-names></name></person-group><article-title>Nifuroxazide attenuates experimentally-induced hepatic encephalopathy and the associated hyperammonemia and cJNK/caspase-8/TRAIL activation in rats</article-title><source>Life Sci</source><year>2020</year><volume>252</volume><fpage>117610</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2020.117610</pub-id><pub-id pub-id-type="pmid">32259601</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Khodir AE, Said E (2020) Nifuroxazide attenuates experimentally-induced hepatic encephalopathy and the associated hyperammonemia and cJNK/caspase-8/TRAIL activation in rats. Life Sci 252:117610<pub-id pub-id-type="pmid">32259601</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><mixed-citation publication-type="other">Li D, Liu X, Liu T, Liu H, Tong L, Jia S, Wang Y-F (2020) Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes. Glia 68:878&#x02013;897</mixed-citation></ref><ref id="CR39"><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>LCD</given-names></name><name><surname>Miranda</surname><given-names>AS</given-names></name><name><surname>Ferreira</surname><given-names>RN</given-names></name><name><surname>Rachid</surname><given-names>MA</given-names></name><name><surname>Silva</surname><given-names>E</given-names></name></person-group><article-title>Hepatic encephalopathy: lessons from preclinical studies</article-title><source>World J Hepatol</source><year>2019</year><volume>11</volume><fpage>173</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.4254/wjh.v11.i2.173</pub-id><pub-id pub-id-type="pmid">30820267</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Lima LCD, Miranda AS, Ferreira RN, Rachid MA, Silva E, A. C. S (2019) Hepatic encephalopathy: lessons from preclinical studies. World J Hepatol 11:173&#x02013;185<pub-id pub-id-type="pmid">30820267</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>Protective effects of Chlorogenic Acid on Cerebral Ischemia/Reperfusion Injury rats by regulating oxidative stress-related Nrf2 pathway</article-title><source>Drug Des Devel Ther</source><year>2020</year><volume>14</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S228751</pub-id><pub-id pub-id-type="pmid">32021091</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Liu D, Wang H, Zhang Y, Zhang Z (2020) Protective effects of Chlorogenic Acid on Cerebral Ischemia/Reperfusion Injury rats by regulating oxidative stress-related Nrf2 pathway. Drug Des Devel Ther 14:51&#x02013;60<pub-id pub-id-type="pmid">32021091</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Tao</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>X</given-names></name></person-group><article-title>Cordycepin ameliorates acute hypobaric hypoxia induced blood-brain barrier disruption, and cognitive impairment partly by suppressing the TLR4/NF-&#x003ba;B/MMP-9 pathway in the adult rats</article-title><source>Eur J Pharmacol</source><year>2022</year><volume>924</volume><fpage>174952</fpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2022.174952</pub-id><pub-id pub-id-type="pmid">35427564</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Liu P, Pan L, Cui L, Li T, Zhao S, Hu Y, Tao X, Deng H, Jiang J, Zhao B, Wang Y, Xue X (2022) Cordycepin ameliorates acute hypobaric hypoxia induced blood-brain barrier disruption, and cognitive impairment partly by suppressing the TLR4/NF-&#x003ba;B/MMP-9 pathway in the adult rats. Eur J Pharmacol 924:174952<pub-id pub-id-type="pmid">35427564</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>B-J</given-names></name><name><surname>Xie</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Bahaji Azami</surname><given-names>NL</given-names></name><name><surname>An</surname><given-names>Y-T</given-names></name><name><surname>Wang</surname><given-names>H-J</given-names></name><name><surname>Ye</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>M-Y</given-names></name></person-group><article-title>BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats</article-title><source>J Ethnopharmacol</source><year>2020</year><volume>249</volume><fpage>112301</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2019.112301</pub-id><pub-id pub-id-type="pmid">31622746</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Lu L, Wu C, Lu B-J, Xie D, Wang Z, Bahaji Azami NL, An Y-T, Wang H-J, Ye G, Sun M-Y (2020) BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats. J Ethnopharmacol 249:112301<pub-id pub-id-type="pmid">31622746</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Azami</surname><given-names>NLB</given-names></name><name><surname>Xie</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Hui</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Song</surname><given-names>J</given-names></name></person-group><article-title>Babao Dan improves neurocognitive function by inhibiting inflammation in clinical minimal hepatic encephalopathy</article-title><source>Biomed Pharmacother</source><year>2021</year><volume>135</volume><fpage>111084</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2020.111084</pub-id><pub-id pub-id-type="pmid">33383371</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Lu B, Wu C, Azami NLB, Xie D, Zhao C, Xu W, Hui D, Chen X, Sun R, Song J (2021) Babao Dan improves neurocognitive function by inhibiting inflammation in clinical minimal hepatic encephalopathy. Biomed Pharmacother 135:111084<pub-id pub-id-type="pmid">33383371</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><mixed-citation publication-type="other">Margulies J, Thompson R, Wycoff K, Detry O, Demetriou A (1999) Aquaporin-4 water channel plays a role in the pathogenesis of cerebral edema in fulminant hepatic failure. Surgical Forum, American College of Surgeons, United States, 46:518&#x02013;520</mixed-citation></ref><ref id="CR45"><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed Kamel</surname><given-names>GA</given-names></name><name><surname>Harahsheh</surname><given-names>E</given-names></name><name><surname>Hussein</surname><given-names>S</given-names></name></person-group><article-title>Diacerein ameliorates acetaminophen hepatotoxicity in rats via inhibiting HMGB1/TLR4/NF-&#x003ba;B and upregulating PPAR-&#x003b3; signal</article-title><source>Mol Biol Rep</source><year>2022</year><volume>49</volume><fpage>5863</fpage><lpage>5874</lpage><pub-id pub-id-type="doi">10.1007/s11033-022-07366-5</pub-id><pub-id pub-id-type="pmid">35366176</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Mohamed Kamel GA, Harahsheh E, Hussein S (2022) Diacerein ameliorates acetaminophen hepatotoxicity in rats via inhibiting HMGB1/TLR4/NF-&#x003ba;B and upregulating PPAR-&#x003b3; signal. Mol Biol Rep 49:5863&#x02013;5874<pub-id pub-id-type="pmid">35366176</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Norenberg</surname><given-names>MD</given-names></name><name><surname>Neary</surname><given-names>JT</given-names></name><name><surname>Norenberg</surname><given-names>L-OB</given-names></name><name><surname>Mccarthy</surname><given-names>M</given-names></name></person-group><article-title>Ammonia Induced decrease in glial fibrillary acidic protein in cultured astrocytes</article-title><source>J Neuropathology Experimental Neurol</source><year>1990</year><volume>49</volume><fpage>399</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1097/00005072-199007000-00004</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Norenberg MD, Neary JT, Norenberg L-OB, Mccarthy M (1990) Ammonia Induced decrease in glial fibrillary acidic protein in cultured astrocytes. J Neuropathology Experimental Neurol 49:399&#x02013;405</mixed-citation></citation-alternatives></ref><ref id="CR47"><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Norenberg</surname><given-names>MD</given-names></name><name><surname>Jayakumar</surname><given-names>AR</given-names></name><name><surname>Rama Rao</surname><given-names>KV</given-names></name></person-group><article-title>Oxidative stress in the pathogenesis of hepatic Encephalopathy</article-title><source>Metab Brain Dis</source><year>2004</year><volume>19</volume><fpage>313</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1023/B:MEBR.0000043978.91675.79</pub-id><pub-id pub-id-type="pmid">15554424</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Norenberg MD, Jayakumar AR, Rama Rao KV (2004) Oxidative stress in the pathogenesis of hepatic Encephalopathy. Metab Brain Dis 19:313&#x02013;329<pub-id pub-id-type="pmid">15554424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Ohnishi</surname><given-names>M</given-names></name><name><surname>Monda</surname><given-names>A</given-names></name><name><surname>Takemoto</surname><given-names>R</given-names></name><name><surname>Fujimoto</surname><given-names>Y</given-names></name><name><surname>Sugitani</surname><given-names>M</given-names></name><name><surname>Iwamura</surname><given-names>T</given-names></name><name><surname>Hiroyasu</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>A</given-names></name></person-group><article-title>High-mobility group box 1 up-regulates aquaporin 4 expression via microglia&#x02013;astrocyte interaction</article-title><source>Neurochem Int</source><year>2014</year><volume>75</volume><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2014.05.007</pub-id><pub-id pub-id-type="pmid">24893328</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Ohnishi M, Monda A, Takemoto R, Fujimoto Y, Sugitani M, Iwamura T, Hiroyasu T, Inoue A (2014) High-mobility group box 1 up-regulates aquaporin 4 expression via microglia&#x02013;astrocyte interaction. Neurochem Int 75:32&#x02013;38<pub-id pub-id-type="pmid">24893328</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><citation-alternatives><element-citation id="ec-CR49" publication-type="book"><person-group person-group-type="author"><name><surname>Pekny</surname><given-names>M</given-names></name><name><surname>Wilhelmsson</surname><given-names>U</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Lajtha</surname><given-names>A</given-names></name><name><surname>Lim</surname><given-names>R</given-names></name></person-group><article-title>GFAP and astrocyte intermediate filaments</article-title><source>Handbook of Neurochemistry and Molecular Neurobiology: neuroactive proteins and peptides</source><year>2006</year><publisher-loc>Boston, MA</publisher-loc><publisher-name>Springer US</publisher-name><fpage>289</fpage><lpage>314</lpage></element-citation><mixed-citation id="mc-CR49" publication-type="book">Pekny M, Wilhelmsson U (2006) GFAP and astrocyte intermediate filaments. In: Lajtha A, Lim R (eds) Handbook of Neurochemistry and Molecular Neurobiology: neuroactive proteins and peptides. Springer US, Boston, MA, pp 289&#x02013;314. <italic>In</italic>:</mixed-citation></citation-alternatives></ref><ref id="CR50"><mixed-citation publication-type="other">Perazzo JC, Tallis S, Delfante A, Souto PA, Lemberg A, Eizayaga FX, Romay S (2012) Hepatic encephalopathy: an approach to its multiple pathophysiological features. World J Hepatol 4:50&#x02013;65</mixed-citation></ref><ref id="CR51"><mixed-citation publication-type="other">Rama Rao KV, Chen M, Simard JM, Norenberg MD (2003) Increased aquaporin-4 expression in ammonia-treated cultured astrocytes. Neuroreport 14:2379&#x02013;2382</mixed-citation></ref><ref id="CR52"><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Rama Rao</surname><given-names>KV</given-names></name><name><surname>Jayakumar</surname><given-names>AR</given-names></name><name><surname>Tong</surname><given-names>X</given-names></name><name><surname>Curtis</surname><given-names>KM</given-names></name><name><surname>Norenberg</surname><given-names>MD</given-names></name></person-group><article-title>Brain Aquaporin-4 in experimental Acute Liver failure</article-title><source>J Neuropathology Experimental Neurol</source><year>2010</year><volume>69</volume><fpage>869</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1097/NEN.0b013e3181ebe581</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Rama Rao KV, Jayakumar AR, Tong X, Curtis KM, Norenberg MD (2010) Brain Aquaporin-4 in experimental Acute Liver failure. J Neuropathology Experimental Neurol 69:869&#x02013;879</mixed-citation></citation-alternatives></ref><ref id="CR53"><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>DO</given-names></name><name><surname>Mansour</surname><given-names>DF</given-names></name><name><surname>Fayez</surname><given-names>AM</given-names></name></person-group><article-title>Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin</article-title><source>Metab Brain Dis</source><year>2021</year><volume>36</volume><fpage>1331</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.1007/s11011-021-00695-7</pub-id><pub-id pub-id-type="pmid">33765229</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Saleh DO, Mansour DF, Fayez AM (2021) Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin. Metab Brain Dis 36:1331&#x02013;1340<pub-id pub-id-type="pmid">33765229</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Sepehrinezhad</surname><given-names>A</given-names></name><name><surname>Zarifkar</surname><given-names>A</given-names></name><name><surname>Namvar</surname><given-names>G</given-names></name><name><surname>Shahbazi</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name></person-group><article-title>Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema</article-title><source>Metab Brain Dis</source><year>2020</year><volume>35</volume><fpage>559</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1007/s11011-020-00549-8</pub-id><pub-id pub-id-type="pmid">32146658</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Sepehrinezhad A, Zarifkar A, Namvar G, Shahbazi A, Williams R (2020) Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema. Metab Brain Dis 35:559&#x02013;578<pub-id pub-id-type="pmid">32146658</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Sepehrinezhad</surname><given-names>A</given-names></name><name><surname>Shahbazi</surname><given-names>A</given-names></name><name><surname>Negah</surname><given-names>SS</given-names></name><name><surname>Joghataei</surname><given-names>MT</given-names></name><name><surname>Larsen</surname><given-names>FS</given-names></name></person-group><article-title>Drug-induced-acute liver failure: a critical appraisal of the thioacetamide model for the study of hepatic encephalopathy</article-title><source>Toxicol Rep</source><year>2021</year><volume>8</volume><fpage>962</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1016/j.toxrep.2021.04.011</pub-id><pub-id pub-id-type="pmid">34026559</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Sepehrinezhad A, Shahbazi A, Negah SS, Joghataei MT, Larsen FS (2021) Drug-induced-acute liver failure: a critical appraisal of the thioacetamide model for the study of hepatic encephalopathy. Toxicol Rep 8:962&#x02013;970<pub-id pub-id-type="pmid">34026559</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><mixed-citation publication-type="other">Shah N, Montes de Oca M, Jover-Cobos M, Tanamoto K, Muroi M, Sugiyama K-I, Davies NA, Mookerjee RP, Dhar DK, Jalan R (2013) Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure.&#x000a0;Liver Transplant 19:751&#x02013;761</mixed-citation></ref><ref id="CR57"><mixed-citation publication-type="other">Shahrokhi N, Khaksari M, Soltani Z, Mahmoodi M, Nakhaee NJ (2010) Effect of sex steroid hormones on brain edema, intracranial pressure, and neurologic outcomes after traumatic brain injury. Can J Physiol Pharmacol 88:414&#x02013;421</mixed-citation></ref><ref id="CR58"><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>NK</given-names></name><name><surname>Mishra</surname><given-names>K</given-names></name></person-group><article-title>Exploration of diacerein as a neuroprotective adjuvant to Adenium obesum: an in-vivo study</article-title><source>J Ayurveda Integr Med</source><year>2023</year><volume>14</volume><fpage>100761</fpage><pub-id pub-id-type="doi">10.1016/j.jaim.2023.100761</pub-id><pub-id pub-id-type="pmid">37506605</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Sharma NK, Mishra K (2023) Exploration of diacerein as a neuroprotective adjuvant to Adenium obesum: an in-vivo study. J Ayurveda Integr Med 14:100761<pub-id pub-id-type="pmid">37506605</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><mixed-citation publication-type="other">Skowro&#x00144;ska M, Zieli&#x00144;ska M, W&#x000f3;jcik-Stanaszek L, Ruszkiewicz J, Milatovic D, Aschner M, Albrecht J (2012) Ammonia increases paracellular permeability of rat brain endothelial cells by a mechanism encompassing oxidative/nitrosative stress and activation of matrix metalloproteinases. J Neurochem 121:125&#x02013;134</mixed-citation></ref><ref id="CR60"><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Suraweera</surname><given-names>D</given-names></name><name><surname>Sundaram</surname><given-names>V</given-names></name><name><surname>Saab</surname><given-names>S</given-names></name></person-group><article-title>Evaluation and management of hepatic encephalopathy: current status and future directions</article-title><source>Gut Liver</source><year>2016</year><volume>10</volume><fpage>509</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.5009/gnl15419</pub-id><pub-id pub-id-type="pmid">27377741</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Suraweera D, Sundaram V, Saab S (2016) Evaluation and management of hepatic encephalopathy: current status and future directions. Gut Liver 10:509&#x02013;519<pub-id pub-id-type="pmid">27377741</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><mixed-citation publication-type="other">Thumburu KK, Dhiman RK, Vasishta RK, Chakraborti A, Butterworth RF, Beauchesne E, Desjardins P, Goyal S, Sharma N, Duseja A, Chawla Y (2014) Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure. J Neurochem 128:617&#x02013;627</mixed-citation></ref><ref id="CR62"><mixed-citation publication-type="other">Vijitruth R, Liu M, Choi D-Y, Nguyen XV, Hunter RL, Bing G (2006) Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson&#x02019;s disease. J Neuroinflammation 3:1&#x02013;16</mixed-citation></ref><ref id="CR63"><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Liang</surname><given-names>G</given-names></name></person-group><article-title>Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosis</article-title><source>Biomed Pharmacother</source><year>2022</year><volume>149</volume><fpage>112917</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2022.112917</pub-id><pub-id pub-id-type="pmid">36068777</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Wang M, Sun J, Yu T, Wang M, Jin L, Liang S, Luo W, Wang Y, Li G, Liang G (2022) Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosis. Biomed Pharmacother 149:112917<pub-id pub-id-type="pmid">36068777</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>